Related Experiment Video
Updated: May 28, 2026

Using Bioluminescent Imaging to Investigate Synergism Between Streptococcus pneumoniae and Influenza A Virus in Infant Mice
Published on: April 14, 2011
Association Between the Introduction of Pediatric Influenza Vaccination and Influenza Diagnoses in Primary Care and
Sílvia Burgaya-Subirana1,2, Anna Ruiz-Comellas2,3,4,5, Queralt Miró-Catalina5
1Pediatrics Department, EAP Manlleu, Institut Català de la Salut, Central Catalonia Primary and Community Care Management, C/Castellot, 17, 08560 Manlleu, Spain.
Insights
Catalonia
Area of Science:
- Public Health
- Epidemiology
- Vaccinology
Background:
- Influenza poses a significant public health burden, with vaccination being the primary prevention strategy.
- Catalonia recommended influenza vaccination for children aged 6–59 months starting in the 2023–24 season.
Purpose of the Study:
- To evaluate the impact of a new pediatric influenza vaccination program on influenza diagnoses and hospitalizations.
- To assess changes in influenza incidence across all age groups following the program's introduction.
Main Methods:
- A quasi-experimental interrupted time series (ITS) analysis was employed.
- Data included all primary care influenza diagnoses and hospitalizations in Central Catalonia (Oct 2018–Aug 2025).
- Segmented negative binomial regression models adjusted for temporal trends, COVID-19, and vaccination rollout.
Main Results:
- A statistically significant decrease in influenza diagnoses was observed in primary care for the 2–4 and 5–14 age groups.
- Initial ITS analysis suggested a 13% reduction in expected influenza cases in primary care for ages 15–64, but this was not sustained upon sensitivity analysis.
- No significant reduction in influenza cases or hospital admissions was found in the hospital setting.
Conclusions:
- The early implementation of systematic pediatric influenza vaccination in Catalonia has not demonstrated a clear association with reduced influenza cases in primary care or hospital settings.
- Further monitoring is needed to assess the long-term impact of the pediatric vaccination program on influenza epidemiology.
Introduction:
Influenza has a major impact on public health. The best way to prevent it is through vaccination. In Catalonia, influenza vaccination has been recommended for children aged 6 to 59 months since the 2023-24 season.
Objective:
To assess the association between the implementation of this vaccination program and changes in influenza diagnoses in primary care and influenza-related hospitalizations in all age groups.
Materials And Methods:
Quasi-experimental study with interrupted time series (ITS) analysis. All influenza diagnoses made in primary care (PC) and all influenza-related hospitalizations in the Central Catalonia health region between October 2018 and August 2025 were included. The monthly aggregated cases were analyzed using segmented negative binomial regression models that accounted for temporal trends, the onset of COVID-19, and the introduction of systematic pediatric influenza vaccination.
Results:
A total of 6804 influenza diagnoses made in PC and 3252 hospitalizations for influenza were analyzed. A statistically significant decrease was observed in the percentage of influenza diagnoses in PC in the 2-4 (13.5% vs. 10.6%) and 5-14 (26.1% vs. 16.3%) age groups. In the ITS analysis conducted in primary care (PC) settings, the vaccination period was significantly associated with a 13% reduction in expected influenza cases among individuals aged 15-64 years (RR 0.87 [0.78; 0.99]). After sensitivity analysis, these results were no longer statistically significant. The ITS analysis in the hospital setting has not shown a significant reduction in expected influenza cases or in expected admissions.
Conclusions:
Systematic influenza vaccination in children aged 6 to 59 months has not been shown to be associated with a reduction in influenza cases in primary care or hospitals settings during the early stages of implementation of the new vaccination program.
Related Concept Videos
Influenza
Vaccinations
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Respiratory Syncytial Virus Disease
Infectious Diseases and Their Occurrence
Steps in Outbreak Investigation

